Chuck Silberstein is Chief Financial Officer at GentiBio. Prior to joining the company, Chuck was the Chief Financial Officer and Head of Business Development at Applied Therapeutics. Preceding Applied Therapeutics, Chuck was Senior Vice President of Corporate Business Development at Allergan, where he led the Ophthalmology Business Development team. Along with broad corporate strategy and business development experience, Chuck has over 17 years of investment and capital markets experience, as a portfolio manager and equity healthcare analyst at The Boston Company Asset Management, Goldman Sachs Asset Management and as a senior healthcare equity analyst at JP Morgan Asset Management. Chuck received his MD from Albert Einstein College of Medicine with Distinction in research in developmental neurobiology and his MBA from Columbia Business School.